Join us on April 2, 2026 at 1:00 PM ET for this session designed for commercial, trade and channel, market access, and patient services teams who are frustrated with opaque data and are ready to move toward transparent, actionable insights.
Learning Objectives:
- Define “black box” data in specialty and rare disease, and explain how it creates blind spots and undermines patient access and revenue.
- Describe the core elements of a transparent data foundation, including validation best practices, accurate patient matching, consent management, and real‑time data availability.
- Apply a practical playbook to evaluate your existing data infrastructure and identify opportunities to enhance visibility, interoperability, and performance across partners.
